Insomnia Disorders: Clinical Trials

2 trials for Insomnia Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Not yet recruiting 1

Follow Insomnia Disorders: new trials by email Literature Review of Insomnia Disorders trials Research Report on Insomnia Disorders

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluating the Efficacy and Safety of PROSOMNIA Sleep Therapy™ in Patients With Sleep Deprivation and Chronic Insomnia
PROSOMNIA Sleep Therapy™ (PSTx), Anesthesia-Induced Sleep Therapy, Diprivan (propofol), Astra-Zeneca - Chronic Insomnia, Sleep Deprivation
Phase 1Not yet recruitingNyree Penn1002025-11-012025-05-28
A Study to Determine the Abuse Potential of Single Oral Doses of Lemborexant Compared to Zolpidem, Suvorexant and Placebo in Healthy, Non-Dependent, Recreational Sedative Users
Zolpidem tablets, Suvorexant tablets, over-encapsulated, Lemborexant tablets - Insomnia Disorders
Phase 1CompletedEisai Inc.392017-04-192020-06-29

Narrower conditions

Sleep Initiation and Maintenance Disorders (2)  ·  Alzheimer Disease (1)  ·  Anxiety Disorders (1)  ·  Cancer Pain (1)  ·  Chronobiology Disorders (1)  ·  Combat Disorders (1)  ·  Depression (1)  ·  Idiopathic Hypersomnia (1)  ·  Pain (1)  ·  Psychological Well-Being (1)  ·  REM Sleep Behavior Disorder (1)  ·  Sleep Deprivation (1)  ·  Sleep Disorders, Circadian Rhythm (1)  ·  Stress Disorders, Post-Traumatic (1)

Broader conditions

Dyssomnias (2)  ·  Mental Disorders (2)  ·  Nervous System Diseases (2)  ·  Sleep Disorders, Intrinsic (2)  ·  Sleep Wake Disorders (2)  ·  Behavior (1)  ·  Behavioral Symptoms (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Dementia (1)  ·  Disorders of Excessive Somnolence (1)  ·  Neurocognitive Disorders (1)  ·  Neurodegenerative Diseases (1)  ·  Neurologic Manifestations (1)  ·  Occupational Diseases (1)

Interventions

Electroencephalography (1)  ·  Propofol (1)  ·  Zolpidem (1)  ·  lemborexant (1)  ·  suvorexant (1)

Sponsors

Eisai Inc. (1)  ·  Nyree Penn (1)

Countries

Canada (1)  ·  United States (1)

Top investigators

Nyree Penn, MHSc., CAA, Master of Health Science (1)

Results publications

PMID 35748777